The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2).
 
Jennifer S. Temel
Research Funding - Helsinn Therapeutics (Inst)
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
David Christopher Currow
Honoraria - prIME Oncology
Consulting or Advisory Role - Mayne Pharma
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
Kenneth Fearon
No Relationships to Disclose
 
Ying Yan
Employment - Helsinn Therapeutics
 
John Friend
Employment - Helsinn Therapeutics
Leadership - Helsinn Therapeutics
 
Amy Pickar Abernethy
Employment - Advoset; AthenaHealth; Flatiron Health; Orange Leaf Associates
Leadership - AAHPM; AAHPM
Stock and Other Ownership Interests - AthenaHealth
Consulting or Advisory Role - ACORN Research; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); Galena Biopharma (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Insys Therapeutics (Inst); KangLaiTe (Inst); Pfizer (Inst)